Bioprinting

3D bioprinting builds functional tissue constructs from cells and biomaterials with multiple clinical trials underway. The session covers skin, cartilage and bone bioprinting (Organovo, CELLINK, BICO platforms), vascularised tissue constructs as a long-standing bottleneck, regulatory pathways under FDA Center for Devices and Radiological Health, in-situ bioprinting in surgery (Pollen Bioprinter for burn patients), bioink innovation including printable hydrogels and decellularised ECM, and the clinical translation of bioprinted organs. Discussion addresses 4D bioprinting with stimuli-responsive materials, bioprinted lung and kidney organ candidates, the manufacturing economics of bioprinted tissues, IP and patent landscape, and the ethical considerations around bioprinted neural tissue.